Acta Scientific Women's Health (ASWH)(ISSN: 2582-3205)

Research Article Volume 3 Issue 6

Oncological and Reproductive Outcome in Epithelial Ovarian Cancer in Women Less than 30 Years of Age

Binamra Sigdel1*, Chitrathara Keshav2, Sanam Puzhakkal3, VP Gangadharan4, Suresh Kayastha1, Remi Abdul Shukur1, Anupana S1 and Tony Augustine1

1Fellow, Department of Surgical and Gynecological Oncology, VPS Lakeshore Hospital, Kochi, Kerala, India
2Consultant, Department of Surgical and Gynecological Oncology, VPS Lakeshore Hospital, Kochi, Kerala, India
3Associate Consultant, Department of Surgical and Gynecological Oncology, VPS Lakeshore Hospital, Kochi, Kerala, India
4Consultant, Department of Medical Oncology, VPS Lakeshore Hospital, Kochi, Kerala, India

*Corresponding Author: Binamra Sigdel, Fellow, Department of Surgical and Gynecological Oncology, VPS Lakeshore Hospital, Kochi, Kerala, India.

Received: April 08, 2021; Published: May 15, 2021

Abstract

Objective: The objective of this study is to evaluate oncological and reproductive outcome of epithelial ovarian cancers and its clinicopathological patterns in patients less than 30 years of age.

Methods: This is a retrospective, single center study and all the patients diagnosed with EOCs from 2014 to 2019 AD who underwent either primary surgery or completion surgery in this center were included in the study. Thirty-six patients with EOCs were identified and their clinicopathological characteristics, overall survival, progression free survival and reproductive outcomes were determined. Mean was used to describe continuous variables whereas frequency and percentages were used to describe categorical variables.

Results: The number of Epithelial Ovarian Cancers in women less than 30 years was 36 (8.07%). The mean age of the patients was 24. The most common mode of presentation was abdominal pain in cases followed by abdominal distension. The most common tumor subtypes were mucinous carcinoma followed by eight cases each of borderline serous and serous carcinoma. Most of the patients presented in early stage of disease. Twenty-two patients (61.12%) underwent fertility sparing surgery. Five patients had recurrence and there was one mortality. The median follow up period was 44 (14 - 90) months. Progression free survival was 37.41 months and overall survival was 44 months. The overall survival rate was 94.45%.

Conclusion: EOCs are rare in young patient and diagnosed at early stage. They have excellent prognosis with fertility sparing surgery and adjuvant chemotherapy and successful pregnancy can be achieved in most of the cases.

 

Keywords: Age Less Than Thirty Years; Malignant Epithelial Ovarian Cancer; Reproductive Outcome; Survival Outcome; Recurrence

References

  1. Berek JS and Bast RC Jr. “Epithelial ovarian cancer”. In: Kufe DW, Pollock RE, Weichselbaum RR et al.,editors. Holland-Frei Cancer Medicine. 6th ed. Hamilton (ON): BC Decker (2003).
  2. Chen LM and Berek JS. “Ovarian and fallopian tubes”. In: Haskell CM, editor. Cancer treatment. 5th ed. Philadelphia, PA: WB Saunders (2000): 55.
  3. Zalel Y., et al. “Diagnosis and management of malignant germ cell ovarian tumours in young females”. International Journal of Gynecology and Obstetrics 55 (1996): 1.
  4. NCCN Guidelines Version 7. 2019 Ovarian Cancer.
  5. Aebi S and Castiglione M. “Epithelial ovarian carcinoma: ESMO clinical recommendations for diagnosis, treatment and follow-up”. Annals of Oncology 30 (2019): 672-705.
  6. Lian L J and Lin QiaoZhi. “Gynecologic Oncology M”. 4th ed. Beijing: People's Health Publishing House, (2006): 551.
  7. Rodriguez M., et al. “National survey of ovarian carcinoma XII. Epithelial ovarian malignancies in women less than or equal to 25 years of age”. Journal of Cancer4 (1994): 1245-1250.
  8. Tang L., et al. “Clinical characteristics and prognosis of epithelial ovarian cancer in young reproductive women”. Ai Zheng = Aizheng = Chinese Journal of Cancer 27 (2008): 951-955.
  9. Tsai J Y., et al. “Diagnosis, pathology, staging, treatment, and outcome of epithelial ovarian neoplasia in patients age < 21 years”. Journal of Cancer11 (2001): 2065- 2070.
  10. Duska L R., et al. “Epithelial ovarian carcinoma in the reroductive age group”. Journal of Cancer12 (1999): 2623-2629.
  11. Chan JK., et al. “Prognostic factors for high-risk early-stage epithelial ovarian cancer: a Gynecologic Oncology Group study”. Cancer 10 (2008): 2202-2210.
  12. Kajiyama H., et al. “Fertility-sparing surgery in young women with invasive epithelial ovarian cancer”. European Journal of Surgical Oncology 36 (2010): 404-408.
  13. Ditto A., et al. “Long-term safety of fertility sparing surgery in early stage ovarian cancer: comparison to standard radical surgical procedures”. Gynecologic Oncology 138 (2015): 78-82.
  14. Fruscio R., et al. “Long-term results of fertility-sparing treatment compared with standard radical surgery for early-stage epithelial ovarian cancer”. British Journal of Cancer 115 (2016): 641-648.
  15. Wright JD., et al. “Fertility preservation in young women with epithelial ovarian cancer”. Cancer 115 (2009): 4118-4126.
  16. Park JY., et al. “Outcomes of laparoscopic fertility-sparing surgery in clinically early-stage epithelial ovarian cancer”. Journal of Gynecologic Oncology 27 (2016): e20.
  17. Kashima K., et al. “Outcomes of fertility-sparing surgery for women of reproductive age with FIGO stage IC epithelial ovarian cancer”. International Journal of Gynecology and Obstetrics 121 (2013): 53-55.
  18. T Satoh., et al. “Outcomes of fertility-sparing surgery for stage I epithelial ovarian cancer: a proposal for patient selection”. Journal of Clinical Oncology10 (2010): 1727-1732.
  19. Lee JY., et al. “Safety of fertility-sparing surgery in primary mucinous carcinoma of the ovary”. Cancer Research and Treatment 47 (2015): 290-297.
  20. Cromi A., et al. “Laparoscopic fertility-sparing surgery for early stage ovarian cancer: a single-centre case series and systematic literature review”. Journal of Ovarian Research 7 (2014): 59.
  21. Ghezzi F., et al. “Laparoscopic fertility-sparing surgery for early ovarian epithelial cancer: a multi-institutional experience”. Gynecologic Oncology 141 (2016): 461-465.
  22. Petrillo M., et al. “Fertility-sparing surgery in ovarian cancer extended beyond the ovaries: a case report and review of the literature”. Gynecologic and Obstetric Investigation 77 (2014): 1-5.
  23. Hu J., et al. “Clinical outcomes of fertility-sparing treatments in young patients with epithelial ovarian carcinoma”. Journal of Zhejiang University Science B 12 (2011): 787-795.
  24. Raspagliesi F., et al. “Conservative surgery in high-risk epithelial ovarian carcinoma”. Journal of the American College of Surgeons 185 (1997): 457-460.
  25. Ditto A., et al. “Fertility sparing surgery in early stage epithelial ovarian cancer”. Journal of Gynecologic Oncology 25 (2014): 320-327.
  26. Ratanasrithong P and Benjapibal M. “Pregnancy outcomes after conservative surgery for early-stage ovarian neoplasms”. Asian Pacific Journal of Cancer Prevention 18 (2017): 2083-2087.
  27. A C Schlaerth., et al. “Long-term survival after fertility-sparing surgery for epithelial ovarian cancer”. International Journal of Gynecological Cancer7 (2009): 1199-1204.
  28. T Satoh., et al. “Outcomes of fertility-sparing surgery for stage I epithelial ovarian cancer: a proposal for patient selection”. Journal of Clinical Oncology10 (2010): 1727-1732.
  29. Jie Yin., et al. “Pregnancy and oncologic outcomes of early stage low grade epithelial ovarian cancer after fertility sparing surgery: a retrospective study in one tertiary hospital of China”. Journal of Ovarian Research 12 (2019): 44.
  30. J M Schilder., et al. “Outcome of reproductive age women with stage IA or IC invasive epithelial ovarian cancer treated with fertility-sparing therapy”. Gynecologic Oncology1 (2002): 1-7.

Citation

Citation: Binamra Sigdel., et al. “Oncological and Reproductive Outcome in Epithelial Ovarian Cancer in Women Less than 30 Years of Age". Acta Scientific Women's Health 3.6 (2021): 69-74.

Copyright

Copyright: © 2021 Binamra Sigdel., et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.




Metrics

Acceptance rate35%
Acceptance to publication20-30 days

Indexed In





News and Events


  • Certification for Review
    Acta Scientific certifies the Editors/reviewers for their review done towards the assigned articles of the respective journals.
  • Submission Timeline for Upcoming Issue
    The last date for submission of articles for regular Issues is July 10, 2022.
  • Publication Certificate
    Authors will be issued a "Publication Certificate" as a mark of appreciation for publishing their work.
  • Best Article of the Issue
    The Editors will elect one Best Article after each issue release. The authors of this article will be provided with a certificate of “Best Article of the Issue”.
  • Welcoming Article Submission
    Acta Scientific delightfully welcomes active researchers for submission of articles towards the upcoming issue of respective journals.
  • Contact US